Gene Vector - Crunchbase Company Profile & Funding

Q: Where is Gene Vector's headquarters?

Gene Vector is located in Chengdu, Sichuan, China.

Q: Who invested in Gene Vector?

Gene Vector has 6 investors including Wuhan East Lake High Technology And Si Chuan Venture Capital.

Q: When was the last funding round for Gene Vector?

Gene Vector closed its last funding round on obfuscated from a Venture - Series Unknown round.

Q: How much funding has Gene Vector raised to date?

Gene Vector has raised obfuscated.

Overview

Gene Vector

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About Gene Vector

CB Rank

117969

Gene Vector is an AAV gene therapy new drug research and development company.

Founded

obfuscation

Private

Venture - Series Unknown

Chengdu, Sichuan, China

1-10

www.jwksw.com/

Biotechnology

Genetics

Funding Rounds

Venture - Series Unknown

OBF

obfuscation

Series A

OBF

obfuscation

Seed

OBF

obfuscation

Details

Legal Name

Chengdu Genevector Biotechnology Co., Ltd.

Also Known As

Genevector, Jinweike

Operating Status

Active

Company Type

For Profit

About the Company

Chengdu Genevector Biotechnology Co., Ltd. (Genevector, Genevector) is a biotechnology company engaged in the research and development of new drugs for adeno-associated virus (AAV) gene therapy. The company is committed to the development of new AAV gene therapy drugs for ophthalmic diseases, neuromuscular diseases, genetic and metabolic diseases,

etc.

Phone Number

1-288-266-9818

Predictions & Insights

Growth Prediction

See this Growth Prediction

Top Contributing Factors

Runway Speculation

Products & Services

JWK001 Injection

An AAV gene therapy drug candidate targeting neovascular age-related macular degeneration (nAMD) by expressing anti-VEGF protein in retinal cells.

JWK002 Injection

An AAV gene therapy drug candidate for X-linked retinoschisis (XLRS), currently in investigator-initiated clinical trials.

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Venture Round - Gene Vector	2	obfuscated obfuscation	Si Chuan Venture Capital, Wuhan East Lake High Technology	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Gene Vector	2	obfuscated obfuscation	Si Chuan Venture Capital, Wuhan East Lake High Technology	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Gene Vector	2	obfuscated obfuscation	Si Chuan Venture Capital, Wuhan East Lake High Technology	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Gene Vector	2	obfuscated obfuscation	Si Chuan Venture Capital, Wuhan East Lake High Technology	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Gene Vector	2	obfuscated obfuscation	Si Chuan Venture Capital, Wuhan East Lake High Technology	Venture - Series Unknown

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Venture Round - Gene Vector	2	obfuscated obfuscation	Si Chuan Venture Capital, Wuhan East Lake High Technology	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Gene Vector	2	obfuscated obfuscation	Si Chuan Venture Capital, Wuhan East Lake High Technology	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Gene Vector	2	obfuscated obfuscation	Si Chuan Venture Capital, Wuhan East Lake High Technology	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Gene Vector	2	obfuscated obfuscation	Si Chuan Venture Capital, Wuhan East Lake High Technology	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Gene Vector	2	obfuscated obfuscation	Si Chuan Venture Capital, Wuhan East Lake High Technology	Venture - Series Unknown

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
Wuhan East Lake High Technology	Yes	Venture Round - Gene Vector	Liao Tong
Wuhan East Lake High Technology	Yes	Venture Round - Gene Vector	Liao Tong
Wuhan East Lake High Technology	Yes	Venture Round - Gene Vector	Liao Tong
Wuhan East Lake High Technology	Yes	Venture Round - Gene Vector	Liao Tong
Wuhan East Lake High Technology	Yes	Venture Round - Gene Vector	Liao Tong